Literature DB >> 31073772

Disparities in Survival and Health Outcomes in Childhood Leukemia.

Lena E Winestone1,2, Richard Aplenc3,4.   

Abstract

PURPOSE OF REVIEW: The aim of this review is to summarize the current literature on pediatric leukemia disparities with attention to not only racial and ethnic disparities, but also socioeconomic disparities. We focus on disparities in survival as well as other health-related outcomes, including end-of-life care and late effects. RECENT
FINDINGS: While progress has been made in decreasing some disparities, most notably in pediatric acute lymphoblastic leukemia, disparities along many axes persist. Proposed etiologies include differences in the genomic alterations of the leukemia itself to differences in access to care that operate through socioeconomic status, insurance, and geographic location. As approaches to therapy become increasingly technical and complex, particular attention to the equitable distribution of these personalized therapeutic interventions is essential. Moving beyond simple descriptive studies to focus on mechanisms of existing disparities will allow for design of interventions to reduce or eliminate disparities in pediatric leukemia.

Entities:  

Keywords:  Disparities; Leukemia; Mortality; Race/ethnicity; Survivorship

Mesh:

Year:  2019        PMID: 31073772     DOI: 10.1007/s11899-019-00515-x

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   3.952


  49 in total

Review 1.  Adequacy of reporting race/ethnicity in clinical trials in areas of health disparities.

Authors:  Giselle Corbie-Smith; Diane Marie M St George; Sandra Moody-Ayers; David F Ransohoff
Journal:  J Clin Epidemiol       Date:  2003-05       Impact factor: 6.437

2.  The importance of race and ethnic background in biomedical research and clinical practice.

Authors:  Esteban González Burchard; Elad Ziv; Natasha Coyle; Scarlett Lin Gomez; Hua Tang; Andrew J Karter; Joanna L Mountain; Eliseo J Pérez-Stable; Dean Sheppard; Neil Risch
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

3.  Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.

Authors:  Nina S Kadan-Lottick; Kirsten K Ness; Smita Bhatia; James G Gurney
Journal:  JAMA       Date:  2003-10-15       Impact factor: 56.272

4.  Advancing health disparities research within the health care system: a conceptual framework.

Authors:  Amy M Kilbourne; Galen Switzer; Kelly Hyman; Megan Crowley-Matoka; Michael J Fine
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

5.  Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.

Authors:  B H Pollock; M R DeBaun; B M Camitta; J J Shuster; Y Ravindranath; D J Pullen; V J Land; D H Mahoney; S J Lauer; S B Murphy
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

6.  Racial and ethnic differences in survival of children with acute lymphoblastic leukemia.

Authors:  Smita Bhatia; Harland N Sather; Nyla A Heerema; Michael E Trigg; Paul S Gaynon; Leslie L Robison
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

7.  Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group.

Authors:  Richard Aplenc; Todd A Alonzo; Robert B Gerbing; Franklin O Smith; Soheil Meshinchi; Julie A Ross; John Perentesis; William G Woods; Beverly J Lange; Stella M Davies
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

8.  Trends in childhood cancer incidence in the U.S. (1992-2004).

Authors:  Amy M Linabery; Julie A Ross
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

9.  Indicators of socioeconomic position (part 1).

Authors:  Bruna Galobardes; Mary Shaw; Debbie A Lawlor; John W Lynch; George Davey Smith
Journal:  J Epidemiol Community Health       Date:  2006-01       Impact factor: 3.710

10.  Chronic health conditions in adult survivors of childhood cancer.

Authors:  Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 176.079

View more
  7 in total

1.  Diverse populations and enrollment in pediatric cancer clinical trials: Challenges and opportunities.

Authors:  Paula Aristizabal
Journal:  Pediatr Blood Cancer       Date:  2020-04-28       Impact factor: 3.167

2.  Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia.

Authors:  Oscar Correa-Jimenez; Juan José Yunis; Adriana Linares-Ballesteros; Isabel Sarmiento-Urbina
Journal:  Colomb Med (Cali)       Date:  2021-09-30

3.  Association of race and ethnicity with clinical phenotype, genetics, and survival in pediatric acute myeloid leukemia.

Authors:  Shannon E Conneely; Casey L McAtee; Rohit Gupta; Joseph Lubega; Michael E Scheurer; Rachel E Rau
Journal:  Blood Adv       Date:  2021-12-14

4.  The Role of Gender-Related Immune Genes in Childhood Acute Myeloid Leukemia.

Authors:  Lu Hao; Qiuyan Chen; Xi Chen; Qing Zhou
Journal:  Biomed Res Int       Date:  2022-09-23       Impact factor: 3.246

5.  Disparities in Pediatric Oncology: The 21st Century Opportunity to Improve Outcomes for Children and Adolescents With Cancer.

Authors:  Paula Aristizabal; Lena E Winestone; Puja Umaretiya; Kira Bona
Journal:  Am Soc Clin Oncol Educ Book       Date:  2021-06

6.  COTI-2 induces cell apoptosis in pediatric acute lymphoblastic leukemia via upregulation of miR-203.

Authors:  Yingmeng Guo; Xia Zhu; Xuerong Sun
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

7.  Childhood cancer mortality trends in the Americas and Australasia: An update to 2017.

Authors:  Matteo Malvezzi; Claudia Santucci; Gianfranco Alicandro; Greta Carioli; Paolo Boffetta; Karina Braga Ribeiro; Fabio Levi; Carlo La Vecchia; Eva Negri; Paola Bertuccio
Journal:  Cancer       Date:  2021-05-27       Impact factor: 6.860

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.